Validation of a brief behavioral economic assessment of demand among cigarette smokers.


Journal

Experimental and clinical psychopharmacology
ISSN: 1936-2293
Titre abrégé: Exp Clin Psychopharmacol
Pays: United States
ID NLM: 9419066

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 29 9 2018
medline: 16 3 2019
entrez: 29 9 2018
Statut: ppublish

Résumé

Basic and clinical addiction research use demand measures and analysis extensively to characterize drug use motivations. Hence, obtaining an accurate and brief measurement of demand that can be easily utilized in different settings is highly valued. In the current study, 2 versions of a breakpoint measure, designed to capture cigarette demand, were investigated in 119 smokers who were recruited from an online crowdsourcing platform. The first version determines the maximum price a smoker is willing to pay for one cigarette received right now when paid out of pocket, and the second determines the maximum price when paid using a hypothetical $100 gift card received for free. The breakpoint measures were administered along with the Cigarette Purchase Task (CPT), Fagerström Test for Cigarette Dependence (FTCD), and The Questionnaire of Smoking Urges (QSU-brief). Both single-item breakpoint versions were significantly correlated with CPT-derived demand measures loaded on the persistence factor (i.e., elasticity of demand, breakpoint, Pmax, and Omax), but not with those loaded on the amplitude factor (i.e., intensity of demand). In addition, both single-item measures were associated with metrics of tobacco dependence (e.g., FTCD, QSU) with effect sizes that are similar to the ones found between CPT-derived breakpoint and those same metrics. These findings suggest that the single-item breakpoint measure is a viable method for measuring demand that may provide a useful and efficient tool to capture crucial and distinct aspects of smoking. In addition, the breakpoint measures may help increase the utility of behavioral demand measures in novel research and clinical settings. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 30265063
pii: 2018-47962-001
doi: 10.1037/pha0000228
pmc: PMC6355365
mid: NIHMS984380
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-102

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA034755
Pays : United States
Organisme : National Institutes of Health
Organisme : Peter Boris Centre for Addiction Research

Références

Nicotine Tob Res. 2001 Feb;3(1):7-16
pubmed: 11260806
J Epidemiol Community Health. 2002 Mar;56(3):163-4
pubmed: 11854332
Nicotine Tob Res. 2016 May;18(5):524-30
pubmed: 26187389
Exp Clin Psychopharmacol. 2006 May;14(2):219-27
pubmed: 16756426
Alcohol Clin Exp Res. 2014 Jun;38(6):1780-9
pubmed: 24890323
Psychopharmacology (Berl). 2016 Jun;233(12):2365-71
pubmed: 27048156
Exp Clin Psychopharmacol. 2015 Oct;23(5):377-86
pubmed: 26147181
Exp Clin Psychopharmacol. 2008 Feb;16(1):57-65
pubmed: 18266552
Exp Clin Psychopharmacol. 2017 Aug;25(4):273-280
pubmed: 28627925
Health Econ. 2014 Jan;23(1):55-68
pubmed: 23303721
Psychol Conscious (Wash D C). 2015 Jun;2(2):144-152
pubmed: 27135038
Patient Prefer Adherence. 2014 Oct 01;8:1353-63
pubmed: 25336926
Exp Clin Psychopharmacol. 2015 Dec;23(6):504-12
pubmed: 26280591
Nicotine Tob Res. 2012 Jan;14(1):75-8
pubmed: 22025545
Psychopharmacology (Berl). 2017 Aug;234(16):2421-2429
pubmed: 28508921
Psychol Rev. 2008 Jan;115(1):186-98
pubmed: 18211190
Psychopharmacology (Berl). 2000 Dec;153(1):44-56
pubmed: 11255928
Addict Behav. 2012 Nov;37(11):1257-63
pubmed: 22727784
Addiction. 2011 Mar;106(3):609-19
pubmed: 21059183
Br J Addict. 1991 Nov;86(11):1467-76
pubmed: 1777741
J Behav Med. 2018 Apr;41(2):269-276
pubmed: 29270887
Exp Clin Psychopharmacol. 1999 Nov;7(4):412-26
pubmed: 10609976
Nicotine Tob Res. 2015 Mar;17(3):292-8
pubmed: 25168032
Am J Public Health. 2000 Jul;90(7):1122-7
pubmed: 10897192
Addiction. 2015 Sep;110(9):1421-8
pubmed: 25732875
Nicotine Tob Res. 2013 Aug;15(8):1409-16
pubmed: 23322768
Health Rep. 2012 Mar;23(1):47-53
pubmed: 22590805
Psychol Addict Behav. 2017 Feb;31(1):85-94
pubmed: 27893213
Nicotine Tob Res. 2012 Dec;14(12):1426-34
pubmed: 22416117
Psychopharmacology (Berl). 2009 Mar;203(1):33-40
pubmed: 18925387
J Abnorm Psychol. 2010 Feb;119(1):106-14
pubmed: 20141247
J Exp Anal Behav. 1980 Sep;34(2):219-38
pubmed: 16812188
Appetite. 2018 Jan 1;120:67-74
pubmed: 28847564
Addiction. 2012 Dec;107(12):2191-200
pubmed: 22845784
Addiction. 2010 Sep;105(9):1599-607
pubmed: 20626376

Auteurs

Liqa N Athamneh (LN)

Addiction Recovery Research Center, Virginia Tech Carilion Research Institute.

Jeffrey S Stein (JS)

Addiction Recovery Research Center, Virginia Tech Carilion Research Institute.

Michael Amlung (M)

Peter Boris Centre for Addictions Research, Department of Psychiatry & Behavioural Neurosciences, McMaster University.

Warren K Bickel (WK)

Addiction Recovery Research Center, Virginia Tech Carilion Research Institute.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH